Dr. M Stephen Mandell Jr., M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 121 Courthouse Ln, Bowling Green, VA 22427 Phone: 804-633-5840 Fax: 804-633-4438 |
Paul T Harvey, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Caroline Detention Facility, 11093 Sw Lewis Memorial Drive, Bowling Green, VA 22427 Phone: 804-633-0043 Fax: 866-475-9337 |
Dr. Daniel William Woodford, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 Courthouse Ln, Bowling Green, VA 22427 Phone: 804-633-5840 Fax: 804-633-4438 |
Dr. Rachna Dhar, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 102 West Broaddus Avenue, Carolina Family Practice, Bowling Green, VA 22427 Phone: 203-520-5583 |
News Archive
Going "off the grid," like rogue secret agents, some bacteria avoid antibiotic treatments by essentially shutting down and hiding until it's safe to come out again, says Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University.
Physicians determining treatment options following abnormal Pap smears now have another factor to consider: the patient's race.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the establishment of a strategic functional service provider relationship with Eli Lilly and Company, a global pharmaceutical company, to support study start-up and site monitoring of clinical trials throughout the Asia/Pacific region. PAREXEL will assist Lilly in bringing greater efficiencies to its clinical research studies to help meet Lilly's development and commercialization goals.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Sunlight Research – The Source for Patent Analysis, today announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types.
› Verified 3 days ago